CN103784946B - 一种治疗尖锐湿疣的药物组合物 - Google Patents
一种治疗尖锐湿疣的药物组合物 Download PDFInfo
- Publication number
- CN103784946B CN103784946B CN201410056312.4A CN201410056312A CN103784946B CN 103784946 B CN103784946 B CN 103784946B CN 201410056312 A CN201410056312 A CN 201410056312A CN 103784946 B CN103784946 B CN 103784946B
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- pharmaceutical composition
- condyloma acuminatum
- stone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010059313 Anogenital warts Diseases 0.000 title claims abstract description 12
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 7
- 241000283956 Manis Species 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 238000002347 injection Methods 0.000 abstract description 12
- 239000007924 injection Substances 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 239000004575 stone Substances 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 230000003442 weekly effect Effects 0.000 abstract description 8
- 231100000614 poison Toxicity 0.000 abstract description 6
- 102000014150 Interferons Human genes 0.000 abstract description 5
- 108010050904 Interferons Proteins 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 229940079322 interferon Drugs 0.000 abstract description 5
- 239000003440 toxic substance Substances 0.000 abstract description 4
- 241000700605 Viruses Species 0.000 abstract description 3
- 208000000260 Warts Diseases 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 210000004877 mucosa Anatomy 0.000 abstract description 2
- 201000010153 skin papilloma Diseases 0.000 abstract description 2
- 230000009897 systematic effect Effects 0.000 abstract description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241000701806 Human papillomavirus Species 0.000 description 4
- 230000003780 keratinization Effects 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 210000004392 genitalia Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 244000119461 Garcinia xanthochymus Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗尖锐湿疣的药物组合物，其特征在于它的原料药重量份如下：丹参6～9g、蓖麻子9～12g、穿山甲3～6g、玄明粉4～6g、花磊石4～6g、栀子6～9g、田基黄4～6g、刘寄奴6～9g、赤芍4～6g、翼首草2～3g。将以上均研粉末用紫草油50毫升调匀备用。干扰素：100万U皮下或肌肉注射，隔日或每周注射2次。本发明中药的有益起效果是：清热解毒，软坚散结，活血化瘀，祛除体表疣体的同时能彻底清除局部皮肤黏膜下的病毒，提高免疫力，系统治疗，达到彻底根治不复发。
Description
技术领域
本发明涉及一种治疗尖锐湿疣的药物组合物。
背景技术
尖锐湿疣是由人乳头瘤病毒(HPV)感染所致的以肛门生殖器部位增生性损害为主要表现的性传播疾病。大多发生于18～50岁的中青年人。大约经过半个月至8个月，平均为3个月的潜伏期后发病。此病较为常见，主要通过性接触传播。最常引起尖锐湿疣的HPV有6、11等。HPV在人体温暖潮湿的条件下易生存繁殖，故外生殖器和肛周是最容易发生感染的部位。
发明内容
本发明中药的有益起效果是：清热解毒，软坚散结，活血化瘀，去除体表疣体的同时能彻底清除局部皮肤黏膜下的病毒，提高免疫力，系统治疗，达到彻底根治不复发。
本发明所要解决的技术问题是为了克服技术上的不足，提供一种疗效好、疗程短，缓解率高，成本低，无毒副作用的一种治疗尖锐湿疣的药物组合物。
为了上述目的，一种治疗尖锐湿疣的药物组合物，其特征在于它的原料药重量份如下：丹参6～9g、蓖麻子9～12g、穿山甲3～6g、玄明粉4～6g、花磊石4～6g、栀子6～9g、田基黄4～6g、刘寄奴6～9g、赤芍4～6g、翼首草2～3g，将以上均研粉末用紫草油50毫升调匀备用。干扰素：100万U皮下或肌肉注射，隔日或每周注射2次。
本发明中药中的丹参味苦，气微寒，无毒。入心、脾二经。活血通经、排脓生肌，专调经脉，理骨筋酸痛，生新血，去恶血。《本草求真》：丹参，书载能入心包络破瘀一语，已尽丹参功效矣。然有论其可以生新安胎，调经除烦，养神定志，及一切风痹、崩带、症瘕、目赤、疝痛、疮疥肿痛等症。蓖麻子属大戟科植物蓖麻的种子，功能主治：消肿拔毒；泻下导滞；通络利窍。主痈疽肿毒；瘰疬、乳痈、喉痹、疥癞癣疮、烫伤、水肿胀满、跌打损伤。穿山甲味咸，性微寒。归肝、胃经。功能与主治：活血消瘕，通经下乳，消肿排脓，搜风通络。用于痈肿疮毒，风湿痹痛……。玄明粉为芒硝经风化干燥制得。主含硫酸钠。功能与主治：泻下通便，润燥软坚，清火消肿。外治咽喉肿痛，口舌生疮，牙龈肿痛，目赤，痈肿，丹毒。花磊石味酸、涩，性平。归肝经。功熊与主治：化瘀止血。栀子清热，泻火，凉血。现代研究，具有抗菌、抗炎及治疗软组织损伤的作用。田基黄是藤黄科植物地耳草的全草。清热利湿，解毒、散瘀消肿。主湿热黄疸；痈疖肿毒、乳蛾、口疮、目赤肿痛、毒蛇咬伤、跌打损伤。抑菌作用：体外试验，田基黄煎剂对常见致病性真菌有明显抑制作用。刘寄奴本品为玄参科植物阴行草的干燥全草。功能与主治：活血祛瘀，通经止痛，凉血，止血，清热利湿。赤芍味苦，性寒。归脾、胃、肝、胆经。功能主治：行瘀、止痛、凉血、消肿。用于温毒发斑，跌扑损伤，痈肿疮疡……。翼首草本品为为川续断科植物匙叶翼首草。功能与主治：解毒除瘟，祛风通痹。紫草油有套盒、收敛的功效。以上药物配伍、相得益彰。
本发明遵循中医的处方原则，水煎服用，经多年临床应用验证，总有效率在96.7％，治愈率83.8％，无毒副作用。
具体实施方式
下面结合实施例对本发明作进一步描述：
实施例1：一种治疗尖锐湿疣的药物组合物，其特征在于它的原料药重量份如下：丹参6～9g、蓖麻子9～12g、穿山甲3～6g、玄明粉4～6g、花磊石4～6g、栀子6～9g、田基黄4～6g、刘寄奴6～9g、赤芍4～6g、翼首草2～3g。将以上均研粉末备用。将以上均研粉末用紫草油50毫升调匀备用。干扰素：100万U皮下或肌肉注射，隔日或每周注射2次。
实施例2：一种治疗尖锐湿疣的药物组合物，其特征在于它的原料药重量份如下：丹参9g、蓖麻子12g、穿山甲3g、玄明粉4g、花磊石4g、栀子9g、田基黄6g、刘寄奴6g、赤芍6g、翼首草2g。将以上均研粉末用紫草油50毫升调匀敷患处，每日2次，每次30分钟。干扰素：100万U皮下或肌肉注射，隔日或每周注射2次。
临床疗效总结：
一、一般资料：本方多年来在临床应用广泛，治疗女性患者66例，年龄在31～56岁，平均39.2岁。疗效频佳。孕妇忌服。
二、诊断标准：有性接触史或间接接触传染史，典型皮损为生殖器或肛周等潮湿部位出现丘疹，乳头状、菜花状或鸡冠状肉质赘生物，表面粗糙角化。2.辅助检查：醋酸白试验阳性，核酸杂交可检出HPV-DNA相关序列，PCR检测可见特异性HPV-DNA扩增区带等。3.患者多有不洁性生活史或配偶感染史，少数尖锐湿疣通过接触污染的用具感染，新生儿亦可通过产道受感染。潜伏期1～8个月不等，平均为3个月。
三、服药方法：将以上均研粉末用紫草油50毫升调匀备用。、成人每日1剂、每剂煎200ml，早、晚分服，每10日为1疗程。干扰素注射液：100万U皮下或肌肉注射1个月，隔日或每周注射2次。
四、疗效判断标准
治愈：临床症状完全消失。
好转：临床症状改善。
无效：临床症状无变化或加重。
五、治疗效果：本发明多年来在临床应用，治疗66例患者，治愈52例83.8％，好转9例，为12.9％；无效1例。总有效率在96.7％，治愈率83.8％。
六、典型病例
1、姜××，女，32岁，2010年6月就诊。主诉乳房下出现皮损，会阴及肛周乳头状肉质赘生物，表面粗糙角化2个月。实验室检查：醋酸白试验阳性。患者要求应用本发明中药20剂外敷，扰素注射液：100万U皮下或肌肉注射1个月，隔日或每周注射2次。临床症状完全消失，半年后随访未再复发。
2、李××，女，39岁，20110年9月就诊，主诉有配偶感染史，肛周出现皮损，乳头状肉质赘生物，表面粗糙角化2个月。实验室检查：醋酸白实验阳性。患者要求应用本发明中药20剂外敷，扰素注射液：100万U皮下或肌肉注射1个月，隔日或每周注射2次。临床症状完全消失，半年后随访未再复发。
3、高×，男，22岁，2012年11月就诊。主诉肛周出现皮损，乳头状肉质赘生物，表面粗糙角化2个月。实验室检查：醋酸白试验阳性。患者要求应用本发明中药20剂外敷，扰素注射液：100万U皮下或肌肉注射1个月，隔日或每周注射2次。临床症状完全消失，半年后随访未再复发。
Claims (1)
1.一种治疗尖锐湿疣的药物组合物，其特征在于它的原料药重量份如下：丹参6～9g、蓖麻子9～12g、穿山甲3～6g、玄明粉4～6g、花蕊石4～6g、栀子6～9g、田基黄4～6g、刘寄奴6～9g、赤芍4～6g、翼首草2～3g，将以上均研粉末用紫草油50毫升调匀备用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410056312.4A CN103784946B (zh) | 2014-02-16 | 2014-02-16 | 一种治疗尖锐湿疣的药物组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410056312.4A CN103784946B (zh) | 2014-02-16 | 2014-02-16 | 一种治疗尖锐湿疣的药物组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103784946A CN103784946A (zh) | 2014-05-14 |
| CN103784946B true CN103784946B (zh) | 2016-06-08 |
Family
ID=50661281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410056312.4A Expired - Fee Related CN103784946B (zh) | 2014-02-16 | 2014-02-16 | 一种治疗尖锐湿疣的药物组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103784946B (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1418685A (zh) * | 2002-11-29 | 2003-05-21 | 张慧芳 | 一种治疗尖锐湿疣的药物组合物及其制备方法 |
| CN1915348A (zh) * | 2006-08-17 | 2007-02-21 | 胡国良 | 一种治疗血瘀型尖锐湿疣的汤剂药物及制备方法 |
| CN102366567A (zh) * | 2011-10-12 | 2012-03-07 | 王世勋 | 一种治疗尖锐湿疣的药物组合物及制备使用方法 |
-
2014
- 2014-02-16 CN CN201410056312.4A patent/CN103784946B/zh not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1418685A (zh) * | 2002-11-29 | 2003-05-21 | 张慧芳 | 一种治疗尖锐湿疣的药物组合物及其制备方法 |
| CN1915348A (zh) * | 2006-08-17 | 2007-02-21 | 胡国良 | 一种治疗血瘀型尖锐湿疣的汤剂药物及制备方法 |
| CN102366567A (zh) * | 2011-10-12 | 2012-03-07 | 王世勋 | 一种治疗尖锐湿疣的药物组合物及制备使用方法 |
Non-Patent Citations (1)
| Title |
|---|
| "中西医结合治疗尖锐湿疣62例";汪玉梅;《中国医学文摘-皮肤科学》;20100430;第27卷(第2期);第77-78页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103784946A (zh) | 2014-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755426B (zh) | 一种用于治疗妇科炎症的中药及制备方法 | |
| CN101085271B (zh) | 一种内服治疗慢性盆腔炎的中药组合物 | |
| CN104189871A (zh) | 一种治疗骨质增生的药酒 | |
| CN101129868A (zh) | 一种内服治疗慢性盆腔炎的中药组合物 | |
| CN103908600B (zh) | 治疗类风湿性关节炎湿热痹阻证的外用药物及制备方法 | |
| CN103007093A (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
| CN102764360B (zh) | 一种治疗急性膀胱炎的中药组合物 | |
| CN104825921A (zh) | 外用治疗湿疹的中药 | |
| CN103784946B (zh) | 一种治疗尖锐湿疣的药物组合物 | |
| CN104147252A (zh) | 一种治疗肝炎的中药制剂 | |
| CN104606639B (zh) | 一种治疗急性乳腺炎乳汁阻塞的中药 | |
| CN103784806B (zh) | 一种治疗风热型荨麻疹的中药 | |
| CN102949467A (zh) | 一种治疗湿热瘀阻所致慢性盆腔炎的药物组合物 | |
| CN103933429A (zh) | 治疗阴道炎的中药组合物 | |
| CN104398613A (zh) | 一种治疗痔疮的中药 | |
| CN104189477A (zh) | 一种治疗脚气的中药配方 | |
| CN102688456B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
| CN103285177A (zh) | 一种治疗褥疮、疔疮的外用膏剂 | |
| CN104688954B (zh) | 一种治疗寒凝血瘀型痛经的中药 | |
| CN103933390B (zh) | 一种治疗乳腺囊性增生的中药制剂 | |
| CN105999033A (zh) | 一种用于护理慢性鼻炎的中药组合物 | |
| CN104644907A (zh) | 一种治疗慢性盆腔炎的中药配方 | |
| CN103386041A (zh) | 用于尖锐湿疣的银倍黄草膏 | |
| CN104147408A (zh) | 一种外用治疗骨质增生的中药 | |
| CN101181471B (zh) | 一种用于治疗盆腔炎的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160608 Termination date: 20220216 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |